Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10

Cancer Letters

Volumn 147, Issue 1-2, 1999, Pages 181-185

  Stone, Joanne G ^a   Eeles, Rosalind A ^a   Sodha, Nayanta ^a   Murday, Victoria ^b   Sheriden, Eamonn ^c   Houlston, Richard S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Bcl 10; Li Fraumeni syndrome

Indexed keywords

ADRENAL CORTEX CARCINOMA; ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER RISK; FAMILIAL CANCER; GENE MUTATION; GENETIC ANALYSIS; LEUKEMIA; PRIORITY JOURNAL; SARCOMA; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; DNA MUTATIONAL ANALYSIS; FAMILY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032709068     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00291-8     Document Type: Article

References (15)

1. Li F.P., Fraumeni J.F. Soft-tissue sarcomas, breast cancer and other neoplasms: a familial syndrome? Ann. Int. Med. 71:1969;747-752.
2. Li F.P., Fraumeni J.F. Prospective study of a cancer family syndrome. J. Am. Med. Asscoc. 247:1982;2692-2694.
3. Li F.P., Fraumeni J.F. Jr., Mulvihill J.J., Blattner W.A., Dreyfus M.G., Tucker M.A., Miller R.W. Cancer family syndrome in twenty-four kindreds. Cancer Res. 48:1988;5358-5362.
4. Varley J.M., Evans D.G., Birch J.M. Li-Fraumeni syndrome - a molecular and clinical review. Br. J. Cancer. 76:1977;1-14.
5. Brugieres L., Gardes M., Moutou C., Chompret A., Meresse V., Martin A., Poisson N., Flamant F., Bonaiti-Pellie C., Lemerle J. Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. Cancer Res. 53:(3):1993;452-455.
6. Eeles R.A. Germline mutations in the TP53 gene. Cancer Surv. 25:1995;101-124.
7. Birch J.M. Li-Fraumeni syndrome. Eur. J. Cancer 30A. 1994;1935-1941.
8. Malkin D., Li F.P., Strong L.C., Fraumeni J.F., Nelson C.E., Kim D.H., Kassel J., Gryka M.A., Bischoff F.Z., Tainsky M.A. Germline p53 mutations in familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 250:1990;1233-1238.
9. Willis T.G., Jadayel D.M., Du D.M.Q., Peng H., Perry A.R., Abdul-Rauf M., Price H., Karran L., Majekodunmi O., Wlodarsk I., Pan L., Crook T., Hamoudi R., Isaacson P.G., Dyer M.J. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 96:(1):1990;1-20.
10. Ganguly A., Rock M.J., Prockop D.J. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc. Natl. Acad. Sci. USA. 90:1993;10325-10329.
11. Lens D., Dyer M.J., Garcia-Marco J.M., De Schouwer P.J., Hamoudi R.A., Jones D., Farahat N., Matutes E., Catovsky D. p53 Abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. Br. J. Haematol. 99:1997;848-857.
12. R.A. Eeles. PhD Thesis, University of London; (1999) Submitted for publication.
13. Hofmann K., Bucher P., Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends Biochem. Sci. 22:1997;155-156.
14. Chou J.J., Matsuo H., Duan H., Wagner G. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-recruitment. Cell. 94:1998;171-180.
15. Fakruddin J.M., Chaganti R.S., Murty V.V. Lack of BCL10 mutations in germ cell tumors and B cell lymphomas. Cell. 97:1999;683-684.